Physician

Ada Tolutope Ogunsiakan, MD

According to 2025 Medicare claims, Ada Ogunsiakan, MD (NPI: 1255862058) practices dermatology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is ESSE DERMATOLOGY (NPI: 1063286482; TIN: 922803909) and primary practice location at 28208-9998. Ogunsiakan is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Ogunsiakan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 51 traditional Medicare patients, billed 175 HCPCS/CPT codes, and received $6,622 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 326 prescription claims across 93 beneficiaries totaling $199,646 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 3 records totaling $136. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,768 to $199,646. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$25K$50K2021 Medicare payment: $11,288 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $49,787 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $30,922 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,622 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202171236$11,288
20222621,102$49,787
2023163845$30,922
202451175$6,622

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$334K$667K2017 Drug cost: $1,768 (USD; Tot_Drug_Cst)2018 Drug cost: $8,307 (USD; Tot_Drug_Cst)2019 Drug cost: $112,721 (USD; Tot_Drug_Cst)2020 Drug cost: $34,280 (USD; Tot_Drug_Cst)2021 Drug cost: $61,474 (USD; Tot_Drug_Cst)2022 Drug cost: $483,468 (USD; Tot_Drug_Cst)2023 Drug cost: $667,347 (USD; Tot_Drug_Cst)2024 Drug cost: $199,646 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R31$1,768
201860137$8,307
201968123$112,721
202055126$34,280
2021104200$61,474
2022265888$483,468
2023199822$667,347
202493326$199,646

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth1213$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2834$61
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1517$54
17000Destruction of precancer skin growth, 1 growth1818$33
17003Destruction of precancer skin growth, 2-14 growths1257$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab13364$50,043
Clobetasol PropionateClobetasol Propionate381,110$2,169
Clindamycin PhosphateClindamycin Phosphate27780$1,042
KetoconazoleKetoconazole641,821$672
CiclopiroxCiclopirox16428$548

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$136REVANCE THERAPEUTICS, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ada Tolutope Ogunsiakan, MD?

Tedicare shows public-source Medicare data for Ada Tolutope Ogunsiakan, MD (NPI 1255862058), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ada Tolutope Ogunsiakan, MD have ACO affiliation data?

Ada Tolutope Ogunsiakan, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Ada Tolutope Ogunsiakan, MD?

Ada Tolutope Ogunsiakan, MD is linked to ESSE DERMATOLOGY (billing NPI 1063286482) in the available physician profile data.

Does Ada Tolutope Ogunsiakan, MD have Open Payments data?

Ada Tolutope Ogunsiakan, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.